Science Explorer Back to mapMap

Most cited papers from Glucox Biotech (Sweden)

What are the most cited papers from Glucox Biotech (Sweden)?

The most cited paper from Glucox Biotech (Sweden) is "The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice" (Enayat Anvari, Pernilla Wikström, Erik Walum et al., 2015), with 101 citations. Next come "The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro" (74) and "Shikonin Increases Glucose Uptake in Skeletal Muscle Cells and Improves Plasma Glucose Levels in Diabetic Goto-Kakizaki Rats" (48).

Showing 15 of 15 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice Enayat Anvari, Pernilla Wikström, Erik Walum et al. · Free Radical Research Open access 29 Jun 2015 101
2 The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro Xuan Wang, Andris Elksnis, Per Wikström et al. · PLoS ONE Open access 28 Sep 2018 74
3 Shikonin Increases Glucose Uptake in Skeletal Muscle Cells and Improves Plasma Glucose Levels in Diabetic Goto-Kakizaki Rats Anette I. Öberg, Kamal Yassin, Robert I. Csikasz et al. · PLoS ONE Open access 26 Jul 2011 48
4 Diphenylene iodonium stimulates glucose uptake in skeletal muscle cells through mitochondrial complex I inhibition and activation of AMP-activated protein kinase Dana S. Hutchinson, Robert I. Csikasz, Daniel L. Yamamoto et al. · Cellular Signalling 22 Feb 2007 45
5 Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy Stavroula Dionysopoulou, Per Wikström, Claudio Bucolo et al. · Diabetes Open access 23 Feb 2023 43
6 A small molecule inhibitor of Nox2 and Nox4 improves contractile function after ischemia–reperfusion in the mouse heart Ferenc L. M. Szekeres, Erik Walum, Per Wikström et al. · Scientific Reports Open access 7 Jun 2021 39
7 Effect of NADPH oxidase inhibitors in an experimental retinal model of excitotoxicity Stavroula Dionysopoulou, Per Wikström, Erik Walum et al. · Experimental Eye Research 9 Sep 2020 19
8 A novel NADPH oxidase inhibitor targeting Nox4 in TGFβ-induced lens epithelial to mesenchymal transition Shannon J. Das, Per Wikström, Erik Walum et al. · Experimental Eye Research 9 Jun 2019 18
9 Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells Andris Elksnis, Jing Cen, Per Wikström et al. · Biomedicines Open access 8 Dec 2021 17
10 Specific NOX4 Inhibition Preserves Mitochondrial Function and Dampens Kidney Dysfunction Following Ischemia–Reperfusion-Induced Kidney Injury Tomas A. Schiffer, Lucas Rannier Ribeiro Antonino Carvalho, Drielle D. Guimarães et al. · Antioxidants Open access 19 Apr 2024 14
11 Investigation of the Effects of a Novel NOX2 Inhibitor, GLX7013170, against Glutamate Excitotoxicity and Diabetes Insults in the Retina Stavroula Dionysopoulou, Per Wikström, Erik Walum et al. · Pharmaceuticals Open access 19 Mar 2024 12
12 The selective NOX4 inhibitor GLX7013159 decreases blood glucose concentrations and human beta-cell apoptotic rates in diabetic NMRI nu/nu mice transplanted with human islets Andris Elksnis, Nils Welsh, Per Wikström et al. · Free Radical Research Open access 16 Nov 2023 6
13 Scandinavian Society for Cell Toxicology – Thirty Years of Scientific Pioneering Erik Walum · Basic & Clinical Pharmacology & Toxicology Open access 15 Jan 2014 4
14 The Tenth Anniversary of the Björn Ekwall Memorial Foundation Erik Walum, Hanna Tähti, Ada Kolman · Alternatives to Laboratory Animals Sep 2011 2
15 Diphenyleneiodonium efficiently inhibits the characteristics of a cancer stem cell model derived from induced pluripotent stem cells Sadia Monzur, Ghmkin Hassan, Said M. Afify et al. · Cell Biochemistry and Function 14 Mar 2022 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.